Turning Point Therapeutics Inc. announced the addition of Barbara Bodem to its board of directors. Ms. Bodem brings extensive operating and board experience, and has been appointed to chair the audit committee. In addition, Garry Nicholson, an existing member of the Turning Point board, has been named interim board chair while a formal search for a permanent chair is ongoing. Former board chair Sheila Gujrathi, M.D., and Jacob Chacko, M.D. have stepped down from the board concurrently with these changes.